NEUROLOGY

Efficiently streamline your Neurology trials with our accelerated recruitment experience, strategic patient retention strategy, and integrated study data.

We understand what is involved in the conduct of successful neurology clinical trials across the critical phases of the clinical trial life cycle.

Oneiric Internationals Neurology clinical trial advantage

  • We have a centralized neuroimaging expertise led by radiologists and neurologists with decades of clinical trial experience.
  • Our medical experts have the expertise to guide and provide strategic direction in the study design and planning aspects.
  • Optimum quality execution standards in trial conduct with the highest efforts and efficiencies directed towards patient recruitment.
  • Specialized and dedicated site network for recruitment of patients with neurological disorders.
  • Well-developed relationships with key opinion leaders in the neuroscience field.
  • Extensive expertise in Neurology in different indications, including migraine disorders.

Types of Neurology Trials:

  • Drug Trials: Investigate the safety and efficacy of new medications for various neurological disorders, including Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, and stroke.
  • Device Trials: Assess the effectiveness and safety of medical devices used in neurology, such as neurostimulation devices, brain-machine interfaces, or diagnostic tools.
  • Neurosurgery Trials: Evaluate new surgical techniques or interventions for neurological conditions, including procedures for epilepsy, movement disorders, or brain tumors.
  • Rehabilitation Trials: Focus on interventions for neurorehabilitation, including physical therapy, occupational therapy, or cognitive rehabilitation.
  • Prevention Trials: Investigate strategies to prevent the development or progression of neurological diseases, including studies on neuroprotective agents, lifestyle modifications, or vaccination.

Endpoints:

  • Common endpoints in neurology trials include improvements in symptoms (e.g., motor function, cognition), disease progression, quality of life, and overall survival.